Between digital therapeutics, HCP portals, and patient support communications, pharma companies are investing a significant portion of their revenues on digital products.
The pharmaceutical industry, with its stringent regulations, demands that healthcare professionals (HCPs) often have to navigate complex onboarding processes to access digital platforms.
In recent years, pharma companies have invested heavily in their healthcare provider (HCP) portals, along with other digital solutions, to account for the reduction in face-to-face time bet
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.